Restenosis after lower extremity interventions: current status and future directions

Area of Science:

• Vascular Surgery
• Interventional Cardiology
• Biomedical Engineering

Background:

• Restenosis, the re-narrowing of arteries, is a significant complication following percutaneous peripheral interventions (PPI).
• The incidence of restenosis varies by vascular bed, with the femoropopliteal and tibioperoneal arteries showing the highest rates.
• Unlike coronary artery restenosis, peripheral restenosis can progress over years post-intervention.

Purpose of the Study:

• To review the incidence of restenosis in lower extremity arterial interventions.
• To evaluate potential pharmacological and non-pharmacological strategies to mitigate restenosis.
• To propose a comprehensive approach for optimizing outcomes in PPI.

Main Methods:

• Literature review of restenosis incidence in lower extremity interventions.
• Analysis of non-pharmacological devices including stents, cryoplasty, atherectomy, and others.
• Evaluation of pharmacological approaches, encompassing systemic and direct drug delivery methods.

Main Results:

• Restenosis rates are highest in the femoropopliteal and tibioperoneal arteries.
• The restenotic process in the periphery is prolonged, extending beyond six months.
• Both device-based and drug-based interventions show potential for altering the restenosis process.

Conclusions:

• Optimizing PPI outcomes requires achieving excellent acute results, protecting the distal tibial bed, and reducing smooth muscle cell proliferation.
• A multi-faceted strategy combining interventional techniques and pharmacological agents is crucial.
• Further research into novel devices and drug delivery systems is warranted to combat peripheral restenosis.